Phase I, dose-escalation study of BIIB022 (anti-IGF-1R antibody) in advanced solid tumors

被引：0
|
作者：
von Mehren, M.
Britten, C.
Lear, K.
Camidge, D. R.
Wainberg, Z. A.
Pieslor, P. C.
Darif, M.
Harris, S.
Balogh, K.
Leong, S.
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Univ Calif Los Angeles, Clin Res Unit, Los Angeles, CA USA
[3] Univ Colorado Denver, Aurora, CO USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[5] Biogen Idec Inc, San Diego, CA USA
[6] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2612
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I dose-escalation study of E6201, a MEK-1 inhibitor, in advanced solid tumors
    Borad, M. J.
    Akerele, C. E.
    Ramanathan, R. K.
    Northfelt, D. W.
    Reyderman, L.
    Verbel, D.
    Feit, K.
    Von Hoff, D. D.
    Tibes, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] BIIB022, a fully human nonglycosylated γ4P antibody targeting IGF-1R for cancer therapy
    Hariharan, Kandasamy
    Dong, Jianying
    Demarest, Stephen
    Joseph, Ingrid
    Chu, Peter
    Graff, Christilyn
    Glaser, Scott
    Kramer-Stickland, Kimberly
    Peach, Robert
    Reff, Mitchell
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3500S - 3500S
  • [33] IMM2510, an anti-PD-L1/VEGF bispecific antibody fusion protein, in patients with advanced solid tumors: A phase I dose-escalation study
    Liu, Rujiao
    Hu, Xichun
    Song, Zhengbo
    Zhang, Jian
    Jin, Jianan
    Gao, Shuiping
    Sun, Yuping
    Zhang, Yan
    Gao, Shegan
    Jia, Ruinuo
    Jing, Deqiang
    Xu, Yu
    Wang, Zhenjiu
    Lu, Qiying
    Tian, Wenzhi
    Cheng, Xiangdong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] A phase I dose-escalation study of the fully human monoclonal antibody MNRP1685A (anti-NRP1) administered intravenously to patients with advanced solid tumors
    Weekes, C.
    Hedge, P.
    Xin, Y.
    Yu, R.
    Xiang, H.
    Gore, L.
    Beeram, M.
    Brachmann, R.
    Patnaik, A.
    EJC SUPPLEMENTS, 2010, 8 (07): : 118 - 118
  • [35] A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumors.
    Berlin, Jordan
    Ramanathan, Ramesh K.
    Strickler, John H.
    Subramaniam, Deeps Suresh
    Hurwitz, Herbert
    Kang, Yoon-Koo
    Kim, Tae-You
    Shepherd, Stacie Peacock
    Xiong, Hao
    Hetman, Robert
    Nickner, Caroline
    Dudley, Matthew W.
    Giranda, Vincent L.
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
    Yamada, Kazuhiko
    Yamamoto, Noboru
    Yamada, Yasuhide
    Nokihara, Hiroshi
    Fujiwara, Yutaka
    Hirata, Taizo
    Koizumi, Fumiaki
    Nishio, Kazuto
    Koyama, Noriyuki
    Tamura, Tomohide
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2528 - 2537
  • [37] A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Leong, Stephen
    Moss, Rebecca A.
    Bowles, Daniel W.
    Ware, Joseph A.
    Zhou, Jing
    Spoerke, Jill M.
    Lackner, Mark R.
    Shankar, Geetha
    Schutzman, Jennifer L.
    van der Noll, Ruud
    Voest, Emile E.
    Schellens, Jan H. M.
    ONCOLOGIST, 2017, 22 (12): : 1491 - 1499
  • [38] Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors
    Luke, Jason J.
    Pinato, David J.
    Juric, Dejan
    Lorusso, Patricia
    Hosein, Peter J.
    Desai, Anupam M.
    Haddad, Robert
    de Miguel, Maria
    Cervantes, Andres
    Kim, Won Seog
    Marabelle, Aurelien
    Zhang, Yan
    Rong, Yuanxin
    Yuan, Xiaobin
    Champiat, Stephane
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [39] Phase I dose-escalation study of ON 01910. Na in combination with oxaliplatin in patients with advanced solid tumors
    Chaudhary, I.
    Rajdev, L.
    Swami, U.
    Wilhelm, F.
    Cohen, B.
    Haigentz, M.
    Kaubisch, A.
    Goel, S.
    Mani, S.
    Ghalib, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] A phase I dose-escalation and PK study of continuous oral rucaparib in patients with advanced solid tumors.
    Kristeleit, Rebecca Sophie
    Shapiro, Geoffrey
    LoRusso, Patricia
    Infante, Jeffrey R.
    Flynn, Michael
    Patel, Manish R.
    Tolaney, Sara M.
    Hilton, John Frederick
    Calvert, Alan Hilary
    Giordano, Heidi
    Isaacson, Jeffrey D.
    Borrow, Jennifer
    Allen, Andrew R.
    Jaw-Tsai, Sarah S.
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345